Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Contribution of neuronal nitric oxide (no) synthase to N-acetylcysteine-induced increase of NO synthase activity in the brain of normotensive and hypertensive rats

O. Pechanova, J. Kunes, Z. Dobesova, S. Vrankova, J. Zicha

. 2009 ; 60 (4) : 21-25.

Jazyk angličtina Země Polsko

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc12025307

The goal of our study was to determine a contribution of nNOS to the increase of brain NO synthase activity induced by chronic N-acetylcysteine (NAC) treatment. Young 4-week-old male Wistar Kyoto rats (WKY) and spontaneously hypertensive rats (SHR) were subjected to treatment with NAC (1.5 g/kg/day) for 8 weeks. At the end of experiment total NOS activity was determined in the brainstem and cerebellum with and without specific nNOS inhibitor S-methyl-L-thiocitrulline (SMTC, 10(-6) mol/l) by measuring the formation of L-[(3)H] citrulline from L-[(3)H] arginine. Chronic NAC treatment had no effect on blood pressure (BP) of WKY, while it attenuated BP increase in young SHR. Total NOS activity was increased in the brainstem of SHR compared to WKY, but this strain difference was abolished by SMTC. Chronic NAC treatment of SHR increased total NOS activity by 32% in the brainstem and by 67% in the cerebellum. After the incubation of brainstem and cerebellum with SMTC there were no significant differences in NOS activity of NAC-treated rats compared to strain-matched controls. Taken together, nNOS seems to be responsible for the increase of total NOS activity in the brain of SHR. SMTC inhibited 86% and 70% of NAC-induced increase of total NOS activity in the brainstem and cerebellum, respectively. Thus, nNOS is responsible not only for strain differences but also for NAC-induced increase of total NOS activity in the brain.

000      
00000naa a2200000 a 4500
001      
bmc12025307
003      
CZ-PrNML
005      
20221005162557.0
007      
ta
008      
120816s2009 pl f 000 0#eng||
009      
AR
035    __
$a (PubMed)20065493
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a pl
100    1_
$a Pecháňová, Oľga, $d 1962- $7 xx0075055 $u Cardiovascular Research Center, Prague, Czech Republic.
245    10
$a Contribution of neuronal nitric oxide (no) synthase to N-acetylcysteine-induced increase of NO synthase activity in the brain of normotensive and hypertensive rats / $c O. Pechanova, J. Kunes, Z. Dobesova, S. Vrankova, J. Zicha
520    9_
$a The goal of our study was to determine a contribution of nNOS to the increase of brain NO synthase activity induced by chronic N-acetylcysteine (NAC) treatment. Young 4-week-old male Wistar Kyoto rats (WKY) and spontaneously hypertensive rats (SHR) were subjected to treatment with NAC (1.5 g/kg/day) for 8 weeks. At the end of experiment total NOS activity was determined in the brainstem and cerebellum with and without specific nNOS inhibitor S-methyl-L-thiocitrulline (SMTC, 10(-6) mol/l) by measuring the formation of L-[(3)H] citrulline from L-[(3)H] arginine. Chronic NAC treatment had no effect on blood pressure (BP) of WKY, while it attenuated BP increase in young SHR. Total NOS activity was increased in the brainstem of SHR compared to WKY, but this strain difference was abolished by SMTC. Chronic NAC treatment of SHR increased total NOS activity by 32% in the brainstem and by 67% in the cerebellum. After the incubation of brainstem and cerebellum with SMTC there were no significant differences in NOS activity of NAC-treated rats compared to strain-matched controls. Taken together, nNOS seems to be responsible for the increase of total NOS activity in the brain of SHR. SMTC inhibited 86% and 70% of NAC-induced increase of total NOS activity in the brainstem and cerebellum, respectively. Thus, nNOS is responsible not only for strain differences but also for NAC-induced increase of total NOS activity in the brain.
650    _2
$a acetylcystein $x farmakologie $7 D000111
650    _2
$a zvířata $7 D000818
650    _2
$a krevní tlak $x účinky léků $7 D001794
650    _2
$a tělesná hmotnost $x účinky léků $7 D001835
650    _2
$a mozek $x účinky léků $x enzymologie $7 D001921
650    _2
$a mozkový kmen $x účinky léků $x enzymologie $7 D001933
650    _2
$a mozeček $x účinky léků $x enzymologie $7 D002531
650    _2
$a vztah mezi dávkou a účinkem léčiva $7 D004305
650    _2
$a scavengery volných radikálů $x farmakologie $7 D016166
650    _2
$a srdce $x anatomie a histologie $x účinky léků $7 D006321
650    _2
$a hypertenze $x farmakoterapie $x enzymologie $7 D006973
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a synthasa oxidu dusnatého $x metabolismus $7 D019001
650    _2
$a synthasa oxidu dusnatého, typ I $x antagonisté a inhibitory $x metabolismus $7 D052248
650    _2
$a velikost orgánu $7 D009929
650    _2
$a náhodné rozdělení $7 D011897
650    _2
$a krysa rodu Rattus $7 D051381
650    _2
$a potkani inbrední SHR $7 D011918
650    _2
$a potkani inbrední WKY $7 D011921
650    _2
$a druhová specificita $7 D013045
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Kuneš, Jaroslav, $d 1948- $7 nlk19990073450
700    1_
$a Dobešová, Zdena, $d 1947- $7 xx0074152
700    1#
$a Vranková, Stanislava. $7 _AN049189
700    1_
$a Zicha, Josef, $d 1950- $7 jk01152609
773    0_
$w MED00002908 $t Journal of physiology and pharmacology $x 1899-1505 $g Roč. 60, č. 4 (2009), s. 21-25
856    41
$u http://www.jpp.krakow.pl/journal/archive/12_09/pdf/21_12_09_article.pdf $y plný text volně přístupný
910    __
$a ABA008 $b sig $c sign $y m $z 0
990    __
$a 20120816 $b ABA008
991    __
$a 20221005162552 $b ABA008
999    __
$a ok $b bmc $g 947349 $s 782653
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2009 $b 60 $c 4 $d 21-25 $i 1899-1505 $m Journal of physiology and pharmacology $n J Physiol Pharmacol $x MED00002908
LZP    __
$a Pubmed-20120816/10/02

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...